MayBank Kim Eng DeClout Ltd (DLL SP) Value creating incubator Tech aggregator with value unlocking track record Listed on the SGX since 2012, DeClout is an incubator of IT infrastructure services and Vertical Domain Cloud (VDC) businesses. Key management have had track records of successfully growing and spinning off tech companies. In its relatively short listing history, DeClout’s biggest success in value unlocking has been the Jul 2016 listing of Procurri (PROC SP, CP SGD0.46, UNRATED), an IT hardware distribution business, which generated ROI of >200% or an unrealized gain of >SGD50m at IPO. This is a first in SGX history for an SGX Catalist Board firm spinning off of a subsidiary to the Main Board. Declout’s current portfolio of firms provides hardware distribution and maintenance (Procurri), ICT solutions (Acclivis & Beacon), e-commerce platform (Corous 360), and e-logistics platform (vCargo Cloud). |
UOB KayHian Singapore Press Holdings (SPH SP) 4QFY16: Earnings To Weaken Further With Economy; Dividends Will Decline Reported FY16 headline profit of S$265m was within expectations. Dividend for FY16 was lower as expected, though from 20 S cents to 18 S cents. The core media business will likely weaken further as the Singapore economy falters, given its correlation to it. Further dividend cuts are likely as a result. We cut core earnings by another 6-8%, on continued weakness from the media business. We update DCF assumptions and our target price falls to S$3.29. Downgrade to SELL. |
OCBC ST Engineering: Secures S$520m of new aerospace contracts
|
|
CIMB RHT Health Trust Completes divestment; special distribution of 24.8 Scts ■ Completes sale of CCDs and CCPS to Fortis Healthcare. ■ Special distribution of 24.8 Scts to unitholders. ■ Maintain Add and DDM-based target price of S$1.11. Completion of sale ● RHT has announced that the proposed disposal of 51% of the compulsorily convertible debentures (CCDs) in Fortis Hospotel Ltd and 100% of the compulsorily convertible preference shares (CCPS) in Escorts Heart Institute and Research Centre Ltd to Fortis Healthcare Ltd have been completed on 14 Oct 2016. The gross consideration totalled Rs14,566.7m (S$301m) while the net proceeds from the disposal amounted to Rs9,602.7m (S$198.5m). |
Check out our compilation of Target Prices